市場調查報告書
商品編碼
1308518
殼聚醣市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會及預測Chitosan Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球殼聚醣市場規模達到23億美元。展望未來,IMARC Group預計到2028年全球甲殼素市場規模將達到46億美元,2023-2028年的複合年成長率(CAGR)將達到12.3%。
殼聚醣是從蝦、蟹、龍蝦以及蘑菇和酵母的硬殼中提取的天然脫乙酰甲殼素。它主要用作治療各種疾病的藥物成分,如腎衰竭、肥胖、貧血、高膽固醇水準、高磷血症、失眠和克隆氏症。在醫藥製造領域,殼聚醣可用於開發可食用薄膜、片劑填料、控釋藥物載體以及改善某些藥物鹽類的溶解性。殼聚醣具有抗菌和抗真菌特性,在化妝品、農業和食品工業中被廣泛用作天然抗菌劑。
醫藥行業的不斷發展以及全球對廢水處理要求的不斷提高是推動市場成長的關鍵因素。在製藥行業,殼聚醣作為一種具有抗菌和抑菌特性的生物材料,在生產生物醫學和組織再生設備、血液透析膜以及藥物輸送系統的植入塗層方面的需求日益成長。此外,水處理廠對該材料的需求也在增加,以去除工業、市政和商業廢物中的雜質,包括重金屬、磷和油類。它還可用作絮凝劑、凝結劑和螯合劑,這也是一個主要的成長誘因。此外,由於其無毒性,殼聚醣正擴大被用作食品添加劑和膳食補充劑。促進市場成長的其他因素包括旨在改善地表水、地下水和飲用水品質的各種政府政策,以及加強從非水生來源開發殼聚醣的研發工作。
The global chitosan market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028.
Chitosan is a naturally occurring deacetylated chitin which is extracted from the hard outer-skeleton or shells of shrimps, crabs and lobsters, along with mushrooms and yeasts. It is primarily used as an ingredient in medicines for treating various conditions, such as kidney failure, obesity, anemia, high cholesterol levels, hyperphosphatemia, insomnia and Crohn's disease. In the pharmaceutical manufacturing sector, chitosan is utilized in the development of edible films; as a filler in tablets; a carrier in controlled-release drugs and to improve the dissolvability of certain medicinal salts. Having antibacterial and antifungal properties, chitosan is extensively used as a natural antimicrobial agent in the cosmetics, agricultural and food industries.
The growing pharmaceutical industry, along with the increasing requirement for wastewater treatment across the globe represent the key factors driving the growth of the market. In the pharmaceutical industry, chitosan being a biomaterial with antibacterial and antimicrobial properties is gaining demand in the production of biomedical and tissue regeneration devices, hemodialysis membranes, and implant coatings for drug delivery systems. Furthermore, its demand is also increasing in the water treatment plants for eliminating impurities present in the industrial, municipal, and commercial waste, including heavy minerals, phosphorous and oils. It is also used as a flocculating, coagulating, and chelating agent, which is further acting as a major growth-inducing factor. Additionally, owing to its non-toxic nature, chitosan is increasingly being adopted as a food additive and dietary supplement. Other factors contributing to the market growth include various government policies aimed to improve the quality of surface, ground and drinking water, coupled with the enhanced research and development (R&D) to develop chitosan from non-aquatic sources.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chitosan market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on grade, source and application.
Industrial Grade
Food Grade
Pharmaceutical Grade
Shrimp
Crab
Squid
Krill
Others
Water Treatment
Food & Beverages
Cosmetics
Medical & Pharmaceuticals
Agrochemicals
Others
Asia Pacific
Europe
North America
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Primex EHF, Heppe Medical Chitosan GmbH, Meron Group, KitoZyme SA, Golden-Shell Pharmaceutical Co. Ltd., FMC Corporation, Agra Tech, Inc., Axio Biosolutions Pvt Ltd and Marshall Marine Products.